BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17895169)

  • 1. Cervene in acute ischemic stroke: results of a double-blind, placebo-controlled, dose-comparison study.
    Clark W; Ertag W; Orecchio E; Raps E
    J Stroke Cerebrovasc Dis; 1999; 8(4):224-30. PubMed ID: 17895169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.
    Clark WM; Raps EC; Tong DC; Kelly RE
    Stroke; 2000 Jun; 31(6):1234-9. PubMed ID: 10835438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of Cervene, a kappa receptor-selective opioid antagonist, in acute ischemic stroke.
    Clark WM; Coull BM; Karukin M; Hendin B; Kelley R; Rosing H; Zachariah S; Winograd M; Raps E; Walshe T; Singer S; Mettinger KL
    J Stroke Cerebrovasc Dis; 1996; 6(1):35-40. PubMed ID: 17894963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.
    Sacco RL; DeRosa JT; Haley EC; Levin B; Ordronneau P; Phillips SJ; Rundek T; Snipes RG; Thompson JL;
    JAMA; 2001 Apr; 285(13):1719-28. PubMed ID: 11277826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
    Grotta J
    Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
    De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
    Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients: a dose-ranging study.
    Lees KR; Dyker AG; Sharma A; Ford GA; Ardron ME; Grosset DG
    Stroke; 2001 Feb; 32(2):466-72. PubMed ID: 11157184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial.
    Lees KR; Lavelle JF; Cunha L; Diener HC; Sanders EA; Tack P; Wester P;
    Cerebrovasc Dis; 2001; 11(1):20-9. PubMed ID: 11173790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
    Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study.
    Abciximab in Ischemic Stroke Investigators
    Stroke; 2000 Mar; 31(3):601-9. PubMed ID: 10700492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
    Clark WM; Albers GW; Madden KP; Hamilton S
    Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.
    Lewandowski CA; Frankel M; Tomsick TA; Broderick J; Frey J; Clark W; Starkman S; Grotta J; Spilker J; Khoury J; Brott T
    Stroke; 1999 Dec; 30(12):2598-605. PubMed ID: 10582984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
    Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
    Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized efficacy trial of citicoline in patients with acute ischemic stroke.
    Clark WM; Williams BJ; Selzer KA; Zweifler RM; Sabounjian LA; Gammans RE
    Stroke; 1999 Dec; 30(12):2592-7. PubMed ID: 10582983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.